Lovastatin alters neurotrophin expression in rat hippocampus‑derived neural stem cells in vitro

• Autorzy: Fakheri F. , Abdanipour A. , Parivan K. , Anarkooli I.J. , Rastegar H.
• Języki publikacji: EN

Abstrakty

EN

Neural stem/progenitor cells hold valuable potential for the treatment of neurodegenerative disorders. The modulation of intrinsic growth factor expression, such as neurotrophins and their receptors, is a necessary step in achieving neural stem cells (NSCs) therapy. The statins have recently been reported to provide both anti‑inflammatory and neuroprotective effects. In the developing and mature nervous systems, neurotrophic factors are known to impact neuronal growth and survival. In this study, we investigated for a positive effect of lovastatin on the expression of neurotrophins in the neonatal rat hippocampus‑derived NSCs. NSCs were isolated and cultured up to passage three. To confirm cellular identity, immunocytochemical evaluation and flow cytometry analysis were performed using specific antibodies. To determine the optimum concentration of lovastatin, the MTT assay was used. Neurotrophin expression was evaluated using quantitative real‑time reverse transcription‑polymerase chain reaction (RT‑qPCR). Flow cytometry results demonstrated that NSCs were positive for nestin, a marker for neural progenitor cells. An increase in cellular viability was observed with a 24 h exposure of lovastatin. Moreover, results showed an increase in mRNA expression for all neurotrophins compared to the control group. Taken together, the results of this study add to the growing body of literature on the neuroprotective effects of statins in neurological disorders. Lovastatin is a promising therapeutic agent for the treatment of neurodegenerative disorders.

• Wydawca: -
• Czasopismo: Acta Neurobiologiae Experimentalis
• Rocznik: 2019
• Tom: 79
• Numer: 4
• Opis fizyczny: p.413-420, fig.,ref.

Twórcy

autor

Fakheri F.

• Science and Research Branch, Department of Biology, Islamic Azad University, Tehran, Iran

autor

Abdanipour A.

• Department of Anatomy, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran

autor

Parivan K.

• Science and Research Branch, Department of Biology, Islamic Azad University, Tehran, Iran

autor

Anarkooli I.J.

• Department of Anatomy, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran

autor

Rastegar H.

• Food and Drug Research Institute, Iran Food and Drug Administration, Ministry of Health and Medical Education, Tehran, Iran
• Food and Drug Control Reference Laboratory, Department of Molecular Biology, Ministry of Health and Medical Education, Tehran, Iran,

Bibliografia

• Barde YA, Edgar D, Thoenen H (1982) Purification of a new neurotrophic factor from mammalian brain. EMBO J 1: 549–553.
• Carson RA, Rudine AC, Tally SJ, Franks AL, Frahm KA, Waldman JK, Silswal N, Burale S, Phan JV, Chandran UR, Monaghan AP, DeFranco DB (2018) Statins impact primary embryonic mouse neural stem cell survival, cell death, and fate through distinct mechanisms. PLoS One 13: e0196387.
• Chen J, Zhang C, Jiang H, Li Y, Zhang  L, Robin A, Katakowski  M, Lu  M, Chopp M (2005) Atorvastatin induction of VEGF and BDNF promotes brain plasticity after stroke in mice. J Cereb Blood Flow Metab 25: 281–290.
• Cho JM, Shin YJ, Park JM, Kim J, Lee MY (2013) Characterization of nestin expression in astrocytes in the rat hippocampal CA1 region following transient forebrain ischemia. Anat Cell Biol 46: 131–140.
• Churchward MA, Todd KG (2014) Statin treatment affects cytokine release and phagocytic activity in primary cultured microglia through two sepa‑ rable mechanisms. Mol Brain 7: 85.
• Dubovy P, Raska O, Klusakova I, Stejskal L, Celakovsky P, Haninec P (2011) Ciliary neurotrophic factor promotes motor reinnervation of the muscu‑ locutaneous nerve in an experimental model of end‑to‑side neurorrha‑ phy. BMC Neurosci 12: 58.
• Frade JM, Barde YA (1998) Nerve growth factor: two receptors, multiple functions. Bioessays 20: 137–145.
• Gao K, Wang G, Wang Y, Han D, Bi J, Yuan Y, Yao T, Wan Z, Li H, Mei X (2015) Neuroprotective effect of simvastatin via inducing the autopha‑ gy on spinal cord injury in the rat model. Biomed Res Int 2015: 260161.
• Guo Q, Liu C, Hai B, Ma T, Zhang W, Tan J, Fu X, Wang H, Xu Y, Song C (2018) Chitosan conduits filled with simvastatin/Pluronic F‑127 hydro‑ gel promote peripheral nerve regeneration in rats. J Biomed Mater Res B Appl Biomater, 106: 787–799.
• Hajar R (2011) Statins: past and present. Heart Views 12: 121–127.
• Han J, Talorete TP, Yamada P, Isoda H (2009) Anti‑proliferative and apop‑ totic effects of oleuropein and hydroxytyrosol on human breast cancer MCF‑7 cells. Cytotechnology 59: 45–53.
• Han X, Yang N, Xu Y, Zhu J, Chen Z, Liu Z, Dang G, Song C (2011) Simvastatin treatment improves functional recovery after experimental spinal cord injury by upregulating the expression of BDNF and GDNF. Neurosci Lett 487: 255–259.
• Ivanisevic L, Saragovi Uri H (2013) Neurotrophins. In: Handbook of Biologi‑ cally Active Peptides (Abba J. Kastin, Ed.). (2nd Edition) Boston Academic Press, p. 1639–1646.
• Kahveci R, Gokce EC, Gurer B, Gokce A, Kisa U, Cemil DB, Sargon MF, Kahveci FO, Aksoy N, Erdoğan B (2014) Neuroprotective effects of ro‑ suvastatin against traumatic spinal cord injury in rats. Eur J Pharmacol 741: 45–54.
• Kim J, Lee S, Choi BR., Yang H, Hwang Y, Park JH, LaFerla FM, Han JS, Lee  KW, Kim J (2017) Sulforaphane epigenetically enhances neuronal BDNF expression and TrkB signaling pathways. Mol Nutr Food Res 61 doi: 10.1002/mnfr.
• Koppula, S, Kumar H, More SV, Kim BW, Kim IS, Choi DK (2012) Recent ad‑ vances on the neuroprotective potential of antioxidants in experimental models of Parkinson’s disease. Int J Mol Sci 13: 10608–10629.
• Levenberg S, Burdick JA, Kraehenbuehl T, Langer R (2005) Neurotrophin‑in‑ duced differentiation of human embryonic stem cells on three‑dimen‑ sional polymeric scaffolds. Tissue Eng 11: 506–512.
• Lin CM, Lin YT, Lin RD, Huang WJ, Lee MH (2015) Neurocytoprotective ef‑ fects of aliphatic hydroxamates from lovastatin, a secondary metabo‑ lite from monascus‑fermented red mold rice, in 6‑hydroxydopamine (6‑OHDA)‑treated nerve growth factor (NGF)‑differentiated PC12 Cells. ACS Chem Neurosci 6: 716–724
• Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real‑time quantitative PCR and the 2(‑Delta Delta C(T)) method. Methods 25: 402–408.
• Malfitano AM, Marasco G, Proto MC, Laezza C, Gazzerro P, Bifulco  M (2014) Statins in neurological disorders: an overview and update. Phar‑ macol Res 88: 74–83.
• McFarland AJ, Anoopkumar‑Dukie S, Arora DS, Grant GD, McDermott CM, Perkins AV, Davey AK (2014) Molecular mechanisms underlying the effects of statins in the central nervous system. Int J Mol Sci 15: 20607–20637.
• Mosley YC, HogenEsch H (2017) Selection of a suitable reference gene for quantitative gene expression in mouse lymph nodes after vaccination. BMC Res Notes 10: 689.
• Nasiri M, Etebari M, Jafarian‑Dehkordi A, Moradi S (2016) Lovastatin pre‑ vents bleomycin‑induced DNA damage to HepG2 cells. Res Pharm Sci 11: 470–475.
• Pall O, Varga B, Collart‑Dutilleul PY, Gergely C, Cuisinier FJG (2017) Re: “An overview of protocols for the neural induction of dental and oral stem cells in vitro” by Heng et al. (Tissue Eng Part B 2016;22: 220–250). Tissue Eng Part B Rev 23: 570–576.
• Proenca CC, Song M, Lee FS (2016) Differential effects of BDNF and neu‑ rotrophin 4 (NT4) on endocytic sorting of TrkB receptors. J Neurochem 138: 397–406.
• Purser MJ, Dalvi PS, Wang ZC, Belsham DD (2013) The cytokine ciliary neu‑ rotrophic factor (CNTF) activates hypothalamic urocortin‑expressing neurons both in vitro and in vivo. PLoS One 8: e61616.
• Quiroz JA, Machado‑Vieira R, Zarate CA Jr, Manji HK (2010) Novel insights into lithium’s mechanism of action: neurotrophic and neuroprotective effects. Neuropsychobiology 62: 50–60.
• Rajanikant GK, Zemke D, Kassab  M, Majid A (2007) The therapeutic potential of statins in neurological disorders. Curr Med Chem 14: 103–112.
• Razavi S, Ghasemi N, Mardani M, Salehi H (2017) Remyelination improve‑ ment after neurotrophic factors secreting cells transplantation in rat spinal cord injury. Iran J Basic Med Sci 20: 392–398.
• Razavi S, Nazem G, Mardani M, Esfandiari E, Salehi H, Esfahani SH (2015) Neurotrophic factors and their effects in the treatment of multiple scle‑ rosis. Adv Biomed Res: 4: 53.
• Robin NC, Agoston Z, Biechele TL, James RG, Berndt JD, Moon RT (2014) Simvastatin promotes adult hippocampal neurogenesis by enhancing Wnt/beta‑catenin signaling. Stem Cell Reports 2: 9–17.
• Roy A, Jana  M, Kundu  M, Corbett GT, Rangaswamy SB, Mishra RK, Luan CH, Gonzalez FJ, Pahan K (2015) HMG‑CoA reductase inhibitors bind to pparalpha to upregulate neurotrophin expression in the brain and improve memory in mice. Cell Metab 22: 253–265.
• Vilar M, Mira H (2016) Regulation of neurogenesis by neurotrophins during adulthood: expected and unexpected roles. Front Neurosci 10: 26. Xiao N, Quynh‑Thu L (2016) Neurotrophic factors and their potential ap‑ plications in tissue regeneration. Arch Immunol Ther Exp 64: 89–99.
• Xu B, Michalski B, Racine RJ, Fahnestock  M (2002) Continuous infusion of neurotrophin‑3 triggers sprouting, decreases the levels of TrkA and TrkC, and inhibits epileptogenesis and activity‑dependent axonal growth in adult rats. Neuroscience 115: 1295–1308.
• Yan JQ, Sun JC, Zhai MM, Cheng LN, Bai XL, Feng CL (2015) Lovastatin induces neuroprotection by inhibiting inflammatory cytokines in 6‑hydroxydopamine treated microglia cells. Int J  Clin Exp Med 8: 9030–9037.
• Yang D, Han Y, Zhang J, Chopp M, Seyfried DM (2012) Statins enhance ex‑ pression of growth factors and activate the PI3K/Akt‑mediated signaling pathway after experimental intracerebral hemorrhage. World J Neuro‑ sci 2: 74–80.
• Zilliox LA, Chadrasekaran K, Kwan JY, Russell JW (2016) Diabetes and cogni‑ tive impairment. Curr Diab Rep 16: 87.

Identyfikatory

DOI

10.21307/ane‑2019‑038